Convenient Synthesis of a 2-Arylcycloheptanone
305
1268, 1069, 787, and 748 cm21; 1H NMR (d): 1.17–1.32 (m, 1H, H-4), 1.46–
1.75 and 2.00–2.12 (m, 8H, H-2, H-3, H-4, H-5, and H-6), 2.20–2.35 (m, 1H,
H-2), 3.12 (t, 1H, J ¼ 4.4, H-7), 3.85 (s, 3H, OCH3), 3.89 (s, 3H, OCH3), 6.82
(dd, 1H, J ¼ 2.0 and 7.6, ArH-40), 6.92 (dd, 1H, J ¼ 2.0 and 7.7, ArH-60) and
7.00 (dd, 1H, J ¼ 7.6 and 7.7, ArH-50); 13C NMR (d): 24.27 (C-4), 24.39 (C-
5), 28.69 (C-3), 30.88 (C-6), 34.32 (C-2), 55.61 (OCH3-30), 60.43 (OCH3-20),
62.44 (C-7), 63.37 (C-1), 111.47 (C-40), 119.01 (C-60), 123.65 (C-50), 137.97
(C-10), 146.50 (C-20), and 152.40 (C-30). HRMS: Found: m/z ¼ 248.14093;
C15H20O3 requires m/z ¼ 248.14125. Anal. calcd. for C15H20O3: C, 72.55;
H, 8.12. Found: C, 72.61; H, 8.15.
2-(20,30-Dimethoxyphenyl) Cycloheptanone (2)
Ten percent Pd/C (26 mg) was added to a solution of oxirane 11 (74 mg,
0.166 mmol) and ammonium formate (56.4 mg, 0.895 mmol) in EtOH
(5 mL), and the system was hydrogenated under atmospheric pressure until
complete consumption of the starting material. Then the catalyst was
filtered through a Celite pad, and the filtrate was concentrated in vacuo.
Chromatography of the residue afforded 7 (38 mg, 51%) and 8 (20 mg,
27%). Compound 7: IR (film, n): 3461, 2929, 2834, 1583, 1464, 1266,
1
1168, 1086, 785, and 747 cm21; H NMR (d): 1.50–1.88 (m, 10H, H-3,
H-4, H-5, H-6 and H-7), 1.91–2.06 (m, 1H, H-2), 3.04–3.15 (m, 1H, H-1),
3.84 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 6.78 (dd, 1H, J ¼ 1.4 and 6.7,
ArH-40), 6.82 (dd, 1H, J ¼ 1.4 and 6.7, ArH-60) and 7.05 (t, 1H, J ¼ 8,
ArH-50); 13C NMR (d): 21.83 (C-6), 27.37 (C-5), 27.72 (C-4), 31.92 (C-3),
35.76 (C-7), 47.56 (C-2), 55.54 (OCH3-30), 60.73 (OCH3-20), 76.83 (C-1),
110.20 (C-40), 119.12 (C-60), 124.40 (C-50), 139.57 (C-10), 146.70 (C-20),
and 152.72 (C-30). Compound 8: IR (film, n): 3482, 2927, 2857, 1583,
1
1476, 1275, 1072, 783, and 749 cm21; H NMR (d): 1.45–1.91 (m, 10H,
H-3, H-4, H-5, H-6, and H-7), 1.94–2.21 (m, 1H, H-2), 3.25 (dt, 1H,
J ¼ 2.1, 2.3, and 11.1, OH), 3.84 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 6.80
(dd, 1H, J ¼ 1.6 and 7.9, ArH-40), 6.86 (dd, 1H, J ¼ 1.6 and 7.9, ArH-60)
and 7.02 (t, 1H, J ¼ 7.9, ArH-50); 13C NMR (d): 21.72 (C-6), 27.01 (C-5),
27.97 (C-4), 28.39 (C-3), 35.34 (C-7), 44.71 (C-2), 55.58 (OCH3-30), 60.70
(OCH3-20), 72.53 (C-1), 110.50 (C-40), 120.80 (C-60), 123.80 (C-50), 139.27
(C-10), and 152.61 (C-20 and C-30). Without further purification, sodium
acetate (12.2 mg, 0.15 mmol) and PCC/Al2O3 (276 mg, 3 equiv.) were succes-
sively added to a mixture of 7 and 8 (19 mg) in CH2Cl2 (5 mL). The reaction
was stirred overnight at room temperature until completion; the solids were
separated by filtration through Celite, the filter was washed with CH2Cl2,
and the filtrate was concentrated under reduced pressure and chromato-
graphed, affording 2 (10.7 mg, 88%) as an oil. IR (film, n): 2931, 2855,
1
1696, 1585, 1453, 1276, 1169, 1084, and 747 cm21; H NMR (d): 1.39–
1.78, 1.89–2.02 and 2.59–2.85 (m, 10H, H-3, H-4, H-5, H-6, and H-7),
3.75 (s, 3H, OCH3), 3.84 (s, 3H, OCH3), 3.89–3.99 (m, 1H, H-2), 6.77